COVID-19 vaccines and anaphylaxis-evaluation with skin prick testing, basophil activation test and Immunoglobulin E.

Csuth, Àgnes; Nopp, Anna; Storsaeter, Jann; Nilsson, Lennart; Jenmalm, Maria C

Csuth, Àgnes; Nopp, Anna; Storsaeter, Jann; Nilsson, Lennart; Jenmalm, Maria C.

Csuth À; Department of Biomedical and Clinical Sciences, Allergy Center, Linköping University, Linköping, Sweden.
Nopp A; Department of Clinical Science and Education, Karolinska Institutet, Stockholm, Sweden.
Storsaeter J; Sachs' Children and Youth Hospital, Södersjukhuset, Stockholm, Sweden.
Nilsson L; Department of Vaccines, Public Health Agency of Sweden, Solna, Sweden.
Jenmalm MC; Department of Biomedical and Clinical Sciences, Allergy Center, Linköping University, Linköping, Sweden.

Clin Exp Allergy ; 52(6): 812-819, 2022 06.

Article in English | MEDLINE | ID: covidwho-1774762

Subject(s)

Anaphylaxis; COVID-19; Anaphylaxis/diagnosis; Anaphylaxis/etiology; Basophil Degranulation Test; Basophils; COVID-19/diagnosis; COVID-19 Vaccines/adverse effects; Humans; Immunoglobulin E; Skin Tests

Keywords

COVID-19; anaphylaxis; basophil activation test; polyethylene glycol; skin prick test; vaccine

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Anaphylaxis Type of study: Diagnostic study / Experimental Studies Topics: Vaccines Limits: Humans Language: English Journal: Clin Exp Allergy Journal subject: Allergy and Immunology Year: 2022 Document Type: Article Affiliation country: Cea.14143

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google